Clinical Trial: Open Label Safety and Efficacy Study of Levetiracetam in Patients With Epilepsy
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A Phase IV, Open-label, Multi-center, Community-based Trial Studying the Safety and Efficacy of Keppra™ as Adjunctive Therapy in Adult Subjects With Uncontrolled Partial Ep
Brief Summary:
Community based study assessing safety and efficacy of levetiracetam in partial onset seizures.
The optimal dose in daily clinical practice will be used.
Detailed Summary:
Sponsor: UCB Pharma
Current Primary Outcome: To assess safety of levetiracetam
Original Primary Outcome: Same as current
Current Secondary Outcome: To evaluate efficacy of levetiracetam in community based practice.
Original Secondary Outcome: Same as current
Information By: UCB Pharma
Dates:
Date Received: September 8, 2005
Date Started: November 2003
Date Completion:
Last Updated: November 14, 2013
Last Verified: July 2010